Free from Publisher

Impact of corticosteroids in hospitalised COVID-19 patients

KS Ho, B Narasimhan, L Difabrizio… - BMJ open …, 2021 - bmjopenrespres.bmj.com
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …
被引用次数：36 相关文章

Impact of corticosteroids in hospitalised COVID-19 patients.

KS Ho, B Narasimhan, L Difabrizio… - BMJ Open …, 2021 - europepmc.org
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …
[PDF] scienceopen.com

[PDF][PDF] Impact of corticosteroids in hospitalised COVID-19 patients

KS Ho, B Narasimhan, L Difabrizio, L Rogers, S Bose… - scienceopen.com
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …
[PDF] archive.org

[PDF][PDF] Impact of corticosteroids in hospitalised COVID-19 patients

KS Ho, B Narasimhan, L Difabrizio, L Rogers, S Bose… - scholar.archive.org
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …

Impact of corticosteroids in hospitalised COVID-19 patients

KS Ho, B Narasimhan, L Difabrizio… - BMJ open …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …
[HTML] nih.gov

[HTML][HTML] Impact of corticosteroids in hospitalised COVID-19 patients

KS Ho, B Narasimhan, L Difabrizio… - BMJ Open …, 2021 - ncbi.nlm.nih.gov
Background Corticosteroids are a potential therapeutic agent for patients with COVID-19
pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data …